- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Baxter International issues urgent correction for certain software versions of infusion pumps
The false alarm may lead to an interruption or delay of therapy, and Baxter has received three reports of serious injury potentially associated with this issue, the regulator said.
Deerfield: Medical device maker Baxter International has issued an urgent correction for certain software versions of its infusion pumps that deliver fluids into a patient's body, the U.S. drug regulator said on Monday.The correction has been issued due to an increase in reported false blockage alarms following the software upgrades in SIGMA Spectrum and Spectrum IQ infusion pumps, the U.S....
Deerfield: Medical device maker Baxter International has issued an urgent correction for certain software versions of its infusion pumps that deliver fluids into a patient's body, the U.S. drug regulator said on Monday.
The correction has been issued due to an increase in reported false blockage alarms following the software upgrades in SIGMA Spectrum and Spectrum IQ infusion pumps, the U.S. Food and Drug Administration said.
Shares of the company, which manufactures dialysis products and infusion pumps, fell 2.5% in morning trade.
The false alarm may lead to an interruption or delay of therapy, and Baxter has received three reports of serious injury potentially associated with this issue, the regulator said.
The company is contacting affected customers to schedule the software reversion, the FDA said, adding that they can continue to use the devices by following certain on-screen instructions to troubleshoot the issue.
Baxter did not immediately respond to Reuters' request for a comment.
Read also: Baxter Veteran James Saccaro to serve as Vice president, CFO of GE HealthCare
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751